166 related articles for article (PubMed ID: 34748253)
21. Neurotoxicity induced by okadaic acid in the human neuroblastoma SH-SY5Y line can be differentially prevented by α7 and β2* nicotinic stimulation.
Del Barrio L; Martín-de-Saavedra MD; Romero A; Parada E; Egea J; Avila J; McIntosh JM; Wonnacott S; López MG
Toxicol Sci; 2011 Sep; 123(1):193-205. PubMed ID: 21715663
[TBL] [Abstract][Full Text] [Related]
22. Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction.
Leuba G; Walzer C; Vernay A; Carnal B; Kraftsik R; Piotton F; Marin P; Bouras C; Savioz A
Neurobiol Dis; 2008 Jun; 30(3):408-419. PubMed ID: 18424056
[TBL] [Abstract][Full Text] [Related]
23. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis.
Lee M; McGeer E; McGeer PL
Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677
[TBL] [Abstract][Full Text] [Related]
24. Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner.
Zhang Z; Simpkins JW
Brain Res; 2010 Jul; 1345():176-81. PubMed ID: 20457142
[TBL] [Abstract][Full Text] [Related]
25. Effect of Inflammatory Mediators Lipopolysaccharide and Lipoteichoic Acid on Iron Metabolism of Differentiated SH-SY5Y Cells Alters in the Presence of BV-2 Microglia.
Pandur E; Varga E; Tamási K; Pap R; Nagy J; Sipos K
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577543
[TBL] [Abstract][Full Text] [Related]
26. Effects of PTEN inhibition on regulation of tau phosphorylation in an okadaic acid-induced neurodegeneration model.
Chen Z; Chen B; Xu WF; Liu RF; Yang J; Yu CX
Int J Dev Neurosci; 2012 Oct; 30(6):411-9. PubMed ID: 22906543
[TBL] [Abstract][Full Text] [Related]
27. Diarrhetic effect of okadaic acid could be related with its neuronal action: Changes in neuropeptide Y.
Louzao MC; Fernández DA; Abal P; Fraga M; Vilariño N; Vieytes MR; Botana LM
Toxicol Lett; 2015 Sep; 237(2):151-60. PubMed ID: 26086426
[TBL] [Abstract][Full Text] [Related]
28. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
29. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
30. Induction of Bcl-2 and Bax was related to hyperphosphorylation of tau and neuronal death induced by okadaic acid in rat brain.
Chen LQ; Wei JS; Lei ZN; Zhang LM; Liu Y; Sun FY
Anat Rec A Discov Mol Cell Evol Biol; 2005 Dec; 287(2):1236-45. PubMed ID: 16265626
[TBL] [Abstract][Full Text] [Related]
31. Secretome from SH-SY5Y APP
Fernandes A; Ribeiro AR; Monteiro M; Garcia G; Vaz AR; Brites D
Biochimie; 2018 Dec; 155():67-82. PubMed ID: 29857185
[TBL] [Abstract][Full Text] [Related]
32. Folic acid inhibits tau phosphorylation through regulation of PP2A methylation in SH-SY5Y cells.
Li W; Jiang M; Xiao Y; Zhang X; Cui S; Huang G
J Nutr Health Aging; 2015 Feb; 19(2):123-9. PubMed ID: 25651436
[TBL] [Abstract][Full Text] [Related]
33. Gc-protein-derived macrophage activating factor counteracts the neuronal damage induced by oxaliplatin.
Morucci G; Branca JJ; Gulisano M; Ruggiero M; Paternostro F; Pacini A; Di Cesare Mannelli L; Pacini S
Anticancer Drugs; 2015 Feb; 26(2):197-209. PubMed ID: 25304987
[TBL] [Abstract][Full Text] [Related]
34. Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia.
Das R; Balmik AA; Chinnathambi S
J Neuroinflammation; 2020 Jan; 17(1):10. PubMed ID: 31915009
[TBL] [Abstract][Full Text] [Related]
35. TREM2 Ameliorates Neuronal Tau Pathology Through Suppression of Microglial Inflammatory Response.
Jiang T; Zhang YD; Gao Q; Ou Z; Gong PY; Shi JQ; Wu L; Zhou JS
Inflammation; 2018 Jun; 41(3):811-823. PubMed ID: 29362997
[TBL] [Abstract][Full Text] [Related]
36. Alterations of Transcription of Genes Coding Anti-oxidative and Mitochondria-Related Proteins in Amyloid β Toxicity: Relevance to Alzheimer's Disease.
Cieślik M; Czapski GA; Wójtowicz S; Wieczorek I; Wencel PL; Strosznajder RP; Jaber V; Lukiw WJ; Strosznajder JB
Mol Neurobiol; 2020 Mar; 57(3):1374-1388. PubMed ID: 31734880
[TBL] [Abstract][Full Text] [Related]
37. The melatonin-N,N-dibenzyl(N-methyl)amine hybrid ITH91/IQM157 affords neuroprotection in an in vitro Alzheimer's model via hemo-oxygenase-1 induction.
Buendia I; Egea J; Parada E; Navarro E; León R; Rodríguez-Franco MI; López MG
ACS Chem Neurosci; 2015 Feb; 6(2):288-96. PubMed ID: 25393881
[TBL] [Abstract][Full Text] [Related]
38. Microglial immunophenotype in dementia with Alzheimer's pathology.
Minett T; Classey J; Matthews FE; Fahrenhold M; Taga M; Brayne C; Ince PG; Nicoll JA; Boche D;
J Neuroinflammation; 2016 Jun; 13(1):135. PubMed ID: 27256292
[TBL] [Abstract][Full Text] [Related]
39. SIRT1 and SIRT2 modulators reduce LPS-induced inflammation in HAPI microglial cells and protect SH-SY5Y neuronal cells in vitro.
Zhang Y; Anoopkumar-Dukie S; Mallik SB; Davey AK
J Neural Transm (Vienna); 2021 May; 128(5):631-644. PubMed ID: 33821324
[TBL] [Abstract][Full Text] [Related]
40. SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability.
Bell M; Zempel H
Rev Neurosci; 2022 Jan; 33(1):1-15. PubMed ID: 33866701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
